Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Advitech Reports Positive Study Results

Advitech Reports Positive Study Results

QUEBEC CITY, QuebecAdvitech Solutions presented results from an ongoing open label clinical study during the 10th International Psoriasis Symposium, held in Toronto June 10 to 13. According to Advitech, the study was designed to evaluate the safety and efficacy of its product, XP-828La mix of growth factors from whey protein, in psoriasis.

Eleven adults with chronic stable plaque psoriasis received 5 g twice daily of XP-828L for 56 days. At the end of the study, seven subjects had an improvement of their psoriasis condition, with no adverse effects reported.

The results of this study will help us in positioning the XP-828L as both a safe and effective solution for treating psoriasis, said Renaud Beauchesne, president and chief executive officer of Advitech (

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.